Product image of Fludeomap (Fludeoxyglucose (18f)) supplied by GNH India

Fludeomap

Active Ingredient:
Fludeoxyglucose (18f)
Origin:
EU

Fludeomap (Fludeoxyglucose (18f))

Fludeoxyglucose (18F) is a radiopharmaceutical used in positron emission tomography (PET) imaging. It helps in visualizing metabolic activity in the body, often for diagnostic purposes.

Manufacturer / TM Owner

Curium Finland Oy

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Fludeoxyglucose (18F) is primarily used in PET scans to detect areas of high metabolic activity. This can be helpful in identifying conditions like cancer, heart disease, and brain disorders. It is administered intravenously and works by highlighting areas where glucose metabolism is elevated.

Side Effects

  • After administration, Fludeoxyglucose (18F) is distributed throughout the body and is taken up by cells with high metabolic rates. This can help in creating detailed images that aid in diagnosis. The effects are typically temporary and related to the imaging process.

Precautions & Warnings

  • Fludeoxyglucose (18F) should be handled with care due to its radioactive nature. It is important to follow safety guidelines to minimize exposure. Patients should inform their healthcare provider about any allergies or medical conditions before administration.

Avoid Interactions

  • Fludeoxyglucose (18F) may interact with other medications or substances that affect glucose metabolism. It is important to discuss all current medications with a healthcare provider to ensure safe use. Alcohol and certain foods may also impact the effectiveness of the imaging process.

Frequently Asked Questions

Fludeoxyglucose (18F) is used in PET scans to visualize areas of high metabolic activity, often for diagnosing conditions like cancer and heart disease.

Fludeoxyglucose (18F) is administered intravenously by a healthcare professional in a controlled medical setting.

Common side effects may include temporary discomfort at the injection site and mild allergic reactions. Serious side effects are rare but should be reported to a healthcare provider.

Patients are often advised to fast for several hours before the scan and to avoid strenuous activity. Specific instructions will be provided by the healthcare provider.

Fludeoxyglucose (18F) is generally safe, but it may not be suitable for everyone. Patients should discuss their medical history and any concerns with their healthcare provider.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Fludeoxyglucose (18f)

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT